Intestinal damage precedes mucosal immune dysfunction in SIV infection.

Hensley-McBain, T., Berard, A., Miller, C., Manuzak, J., Zevin, A.S., Firpo, P., Gile, J., Agricola, B., Cameron, M., Hu, S-L., Reeves, R.K., Smedley, J., Keel, B.F., Burgener, A, and Klatt, N.R. Intestinal damage precedes mucosal immune dysfunction in SIV infection. 2018. Mucosal Immunol. doi: 10.1038/s41385-018-0032-5. PMID: 29907866

Short Communication: Apoptotic Membrane Microparticles Quantified by Fluorescent Bead-Based Assay Are Elevated in HIV and SIV Infections.

Autissier, E., Li, H., Goepfert, P., and Reeves, R.K. Short Communication: Apoptotic Membrane Microparticles Quantified by Fluorescent Bead-Based Assay Are Elevated in HIV and SIV Infections. 2018. AIDS Res. Hum. Retroviruses. 34(5):446-448. PMID: 29486582. PMCID: PMC5934972

Zika virus persistence in the central nervous system and lymph nodes of rhesus monkeys.

Aid M, Abbink P, Larocca RA, Boyd M, Nityanandam R, Nanayakkara O, Martinot AJ, Moseley ET, Blass E, Borducchi EN, Chandrashekar A, Brinkman AL, Molloy K, Jetton D, Tartaglia LJ, Liu J, Best K, Perelson AS, De La Barrera RA, Lewis MG, Barouch DH. Zika virus persistence in the central nervous system and lymph nodes of rhesus monkeys. Cell 2017; 169:610-620.

Asymmetric recognition of HIV-1 Envelope trimer by V1V2 loop-targeting antibodies.

Wang H, Gristick HB, Scharf L, West AP, Galimidi RP, Seaman MS, Freund NT, Nussenzweig MC, Bjorkman PJ. Asymmetric recognition of HIV-1 Envelope trimer by V1V2 loop-targeting antibodies. Elife. 2017 May 26;6.

Innate Lymphoid Cells in HIV/SIV Infections.

Shah, S., Manickam, C., Ram, D., and Reeves, R.K. 2017. Innate Lymphoid Cells in HIV/SIV Infections. Front. Immunol. 8:1818. PMID: 29326704. PMCID: PMC5733347

Retroviral intasomes arising.

Engelman AN, Cherepanov P. Retroviral intasomes arising. Curr Opin Struct Biol 2017 Dec 27;47:23-29. doi: 10.1016/j.sbi.2017.04.005. Epub 2017 Apr 28. PubMed PMID: 28458055; PubMed Central PMCID: PMC5660667.

Boosting of HIV envelope CD4 binding site antibodies with long variable heavy third complementary determining region in the randomized double blind RV305 HIV-1 vaccine trial.

Easterhoff D, Moody MA, Fera D, Cheng H, Ackerman M, Wiehe K, Saunders KO, Pollara J, Vandergrift N, Parks R, Kim J, Michael NL, O’Connell RJ, Excler JL, Robb ML, Vasan S, Rerks-Ngarm S, Kaewkungwal J, Pitisuttithum P, Nitayaphan S, Sinangil F, Tartaglia J, Phogat S, Kepler TB, Alam SM, Liao HX, Ferrari G, Seaman MS, Montefiori DC, Tomaras GD, Harrison SC, Haynes BF. Boosting of HIV envelope CD4 binding site antibodies with long variable heavy third complementary determining region in the randomized double blind RV305 HIV-1 vaccine trial. PLoS Pathog. 2017 Feb 24;13(2):e1006182.

Mauritian cynomolgus macaques with M3M4 MHC genotype control SIVmac251 infection.

Li H, Omange RW, Czarnecki C, Correia-Pinto JF, Crecente-Campo J, Richmond M, Li L, Schultz-Darken N, Alonso MJ, Whitney JB, Plummer FA, Luo M. Mauritian cynomolgus macaques with M3M4 MHC genotype control SIVmac251 infection. J Med Primatol. 2017 Aug;46(4):137-143. doi: 10.1111/jmp.12300. PMID: 28748659; PMCID: PMC5560087.

Retroviral integrase protein and intasome nucleoprotein complex structures.

Grawenhoff J, Engelman AN. Retroviral integrase protein and intasome nucleoprotein complex structures. World J Biol Chem 2017 Feb 26;8(1):32-44. doi: http://dx.doi.org/10.4331/wjbc.v8.i1.32. PubMed PMID: 28289517; PubMed Central PMCID: PMC5329712.

Broadly neutralizing antibodies suppress post-transcytosis HIV-1 infectivity.

Lorin V, Malbec M, Eden C, Bruel T, Porrot F, Seaman MS, Schwartz O, Mouquet H. Broadly neutralizing antibodies suppress post-transcytosis HIV-1 infectivity. Mucosal Immunol. 2017 May; 10(3):814-826.